Daniel Loeb’s HCA Healthcare HCA Stock Holding History

Daniel Loeb’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-600,000	Closed	-$182M	–	45
2023 Q2	$182M	Sell	600,000 -260,000	-30%	-$72.3M	2.67%	13
2023 Q1	$227M	Buy	+860,000	New	+$218M	3.71%	9

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Daniel Loeb's HCA Position: Q3 2023 in Review

Daniel Loeb sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 600,000 shares — an estimated $182M sold.

Daniel Loeb first reported a position in HCA in Q1 2023 and held it in 2 quarters. The position peaked at $227M in Q1 2023. 1,001 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

Daniel Loeb reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
Daniel Loeb sold 600,000 HCA Healthcare shares in Q3 2023, an estimated $182M.
Daniel Loeb first reported a position in HCA Healthcare in Q1 2023 and held it in 2 quarters.
Daniel Loeb's HCA Healthcare position peaked at $227M in Q1 2023.
1,001 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Third Point's 13F filing for Q3 2023, filed 14 Nov 2023.